Amgen commits for another five years as title sponsor of the Amgen Singelloop Breda

Amgen will remain associated with the Amgen Singelloop Breda as title sponsor for the next five years. Following years of involvement with the Breda running event, Amgen has chosen to continue with Le Champion as the new organizer. Together they will build on the further development of this sporting event, while maintaining its character and strong connection to the city.

The 39th edition of the Amgen Singelloop Breda will take place on Sunday, April 4, 2027. From this edition onwards, the organization is in the hands of Stichting Sportevenementen Le Champion. The familiar character remains central, with the course along the canals and through the historic city center, and the great involvement of participants, volunteers, supporters, and residents.

“The five-year partnership with Amgen gives great confidence in the future of the Amgen Singelloop Breda,” says René Wit, director of events at Le Champion. “We share the ambition to get people moving and to further develop this strong Breda tradition. Amgen's long-term commitment and local connection are of great value in this regard.”

“It is great news for the Breda community, all runners and our own Amgen Singelloop enthusiasts that the Amgen Singelloop Breda is being continued,” responds Femmy de Rijk, Head of Corporate Affairs, Amgen Breda. “For years, this special event has stood for movement, vitality, and connection; values that are also important to us at Amgen. We are therefore starting off with great enthusiasm and look forward to working together with Le Champion to continue building on this beautiful Breda tradition together.”

Registration opens at the end of August
For the 39th edition of the Amgen Singelloop Breda, there is room for a maximum of 24,000 runners. Participants can choose from the Kids Run, Family Run, 5 km, 10 km, and 21.1 km. Registration for these distances opens on August 31, 2026, at 9:00 AM. New in 2027 is the Singel Wandeltocht Breda on Saturday, April 3, 2027, with room for up to 5,000 walkers.

About the Amgen Singelloop Breda
Since 1986, the Amgen Singelloop Breda has brought runners, supporters, residents, volunteers, businesses, and partners together in Breda. The course runs along the canals and through the historic city center, finishing on the Grote Markt next to the Grote Kerk. From 2027, Stichting Sportevenementen Le Champion organizes the Amgen Singelloop Breda.

About Amgen
Amgen discovers, develops, manufactures, and delivers innovative medicines for people with serious illnesses. By combining the power of biology and technology, Amgen reaches millions of patients worldwide with its medicines. As a pioneer in the biotechnology industry, Amgen has played a leading role for more than 45 years in pushing the boundaries of science and innovation, partly with the help of advanced technology and human genetic data.

In the Netherlands, Amgen is located in Breda. From Breda, medicines are labeled, packaged, and distributed to Europe and a large number of countries beyond. In addition, Amgen Netherlands ensures the availability of medicines and clinical trials in the Netherlands.

The product portfolio includes treatments in oncology, hematology, cardiovascular diseases, bone diseases, and (rare) inflammatory diseases. For more information, please visit Amgen.nl